Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.760
-0.020 (-0.72%)
At close: Mar 30, 2026, 4:00 PM EDT
2.730
-0.030 (-1.09%)
After-hours: Mar 30, 2026, 5:48 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $422.34 million as of March 30, 2026. Its market cap has increased by 26.80% in one year.
Market Cap
422.34M
Enterprise Value
290.23M
1-Year Change
26.80%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has decreased from $423.19M to $422.34M, a decrease of -0.20%. That is a compound annual growth rate of -0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 425.40M | -18.94% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 442.69M |
| Nautilus Biotechnology | 440.44M |
| Assembly Biosciences | 439.40M |
| Immix Biopharma | 431.66M |
| Shattuck Labs | 430.82M |
| Entrada Therapeutics | 429.48M |
| enGene Holdings | 426.72M |
| Eupraxia Pharmaceuticals | 412.76M |